Recombinant Hepatitis B Vaccine （Saccharomyces cerevisiae）(Beijing Institute of Biological Products)

重组乙型肝炎疫苗(酿酒酵母)（北京生物制品研究所）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant Hepatitis B Vaccine （Saccharomyces cerevisiae）(Beijing Institute of Biological Products)
Drug Alias NameN/A
ClassificationVaccines > National Immunization Program > Immunization program vaccine(Class I)Vaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaHepatitis B
Original Approved Country/TerritoryMainland China
Original Approved Date1998/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeJ07BC01
Related LinksN/A